Research peptide · Other compounds research
Lanreotide
Also known as lanreotide acetate
A synthetic cyclic octapeptide analog of somatostatin that is also one of the best characterized self-assembling peptides, forming monodisperse beta-sheet nanotubes in water.
- Compound type
- Research peptide
- Research area
- Other compounds
- Formula
- C54H69N11O10S2
- Average mass
- 1,096.323 Da
- Monoisotopic mass
- 1,095.467 Da
- PubChem
- CID 6918011
What it is
Lanreotide is a synthetic eight-residue peptide. Its molecular formula is C54H69N11O10S2, its average mass is 1096.32 g/mol and its monoisotopic mass is 1095.47. It is indexed as PubChem CID 6918011.
Chemically it belongs to the cyclic octapeptide class modeled on somatostatin-14, in which a disulfide-closed ring carries the residues that contact the somatostatin receptors. In receptor pharmacology it is classified as an agonist with preference for somatostatin receptor 2 3.
Structure and chemistry
The sequence is D-2-naphthylalanine-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2, with a disulfide bridge between the two cysteines and an amidated C-terminus. Three positions depart from ordinary L-peptide chemistry: the N-terminal D-2-naphthylalanine, the D-tryptophan inside the ring, and the amide cap. The naphthyl, indole and phenol groups together dominate the hydrophobic face of the molecule and give strong ultraviolet absorbance.
That aromatic face also makes lanreotide unusual among peptide drugs: in water above a threshold concentration it assembles spontaneously into beta-sheet nanotubes of uniform diameter, rather than into disordered aggregates 1. The assembly is reversible and concentration dependent, which is why the compound became a model system for peptide self-assembly as well as a receptor ligand.
How it is studied in the laboratory
Self-assembly is the largest independent research line. A 2003 study combined small-angle X-ray scattering, electron microscopy and optical methods to show that the octapeptide forms nanotubes of a single, well-defined diameter in the range of viral capsids 1. A 2022 cryo-electron microscopy study resolved the atomic structure of those nanotubes and described the packing of the peptide dimers that build the wall 2.
Receptor work has been structural. A 2022 cryo-electron microscopy study determined the somatostatin receptor 2 and Gi protein complex bound to lanreotide, octreotide and somatostatin-14 at resolutions near 2.9 angstroms, and analyzed the ring residues that contact the receptor 3.
Analytical notes
Identity is confirmed by liquid chromatography with mass spectrometry in positive ion mode. The expected singly protonated ion falls near m/z 1096.47 and the doubly protonated ion near m/z 548.74. These values are calculated on the monoisotopic mass of 1095.47, so a certificate calculated on the average mass of 1096.32 will read about one mass higher.
Purity is assessed by reversed-phase HPLC with ultraviolet detection, where the naphthyl and indole groups give a strong signal. Two features complicate the chromatography. The self-assembly behavior means sample concentration and buffer can change the apparent peak shape, so dilute conditions are preferred for analysis. For a disulfide-closed peptide the informative impurities are the reduced open-chain form, disulfide-linked dimers, and diastereomers from epimerization at the D-residues.
Storage and handling in the laboratory
As supplied, the material is a lyophilized powder, stored at -20 degrees Celsius, sealed and protected from light. The lyophilized state is hygroscopic, so a sealed vial should reach room temperature before opening. Disulfide-containing peptides are the ones most affected by trace reducing agents and by alkaline conditions, which promote scrambling.
Open questions in the literature
The relationship between the assembled state and receptor engagement is not resolved: the structural work on nanotubes and the structural work on the receptor complex describe the same molecule in different states, and the exchange between them under assay conditions is not well characterized 23. Subtype selectivity across the five somatostatin receptors remains inferred largely from binding data.
Identity check
A mass-spectrometry result for Lanreotide should show peaks near these values. A result more than about one unit away is worth a question to the testing lab. Salt forms such as acetate or TFA do not move these peaks, though they do mean less peptide in each milligram of powder.
| Ion | Expected m/z |
|---|---|
| [M+H]+ | 1096.47 |
| [M+2H]2+ | 548.74 |
References
- Valery C, Paternostre M, Robert B, et al. Biomimetic organization: octapeptide self-assembly into nanotubes of viral capsid-like dimension. Proceedings of the National Academy of Sciences. 2003;100(18):10258-10262. doi:10.1073/pnas.1730609100. Source
- Pieri L, Wang F, Arteni AA, et al. Atomic structure of lanreotide nanotubes revealed by cryo-EM. Proceedings of the National Academy of Sciences. 2022;119(4):e2120346119. doi:10.1073/pnas.2120346119. Source
- Bo Q, Yang F, Li Y, et al. Structural insights into the activation of somatostatin receptor 2 by cyclic SST analogues. Cell Discovery. 2022;8(1):47. doi:10.1038/s41421-022-00405-2. Source
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.
